Advicenne Combined Shareholders Meeting to Be Held on May 26 Behind Closed Doors

May 5, 2020

Nîmes, France, March 13, 2020 – 7:45 a.m. CET – Advicenne (Euronext Paris & Brussels: ADVIC – FR0013296746), a specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare kidney diseases, today announced its financial results for the year ended December 31, 2019 and confirmed its 2020 operational outlook.